A Meta-Analysis of the Efficacy of Prokinetic Agents against Glycemic Control

Table 1

Main characteristics.

Studies	Treatment	Mechanism of action	Treatment period
Melga, P. et al., 1997	Levosulpiride	Dopamine antagonist	24 weeks
Nam, J. S. et al., 2010	Mosapride	5-HT4 agonist	2 weeks
Ueno, N. et al., 2000	Erythromycin	Motilin agonist	4 weeks
Ueno, N. et al., 2001	Erythromycin	Motilin agonist	4 weeks
Ueno, N. et al., 2002	Mosapride	5-HT4 agonist	8 weeks

5-HT₄: 5-hydroxytryptamine receptor 4.